|
SEC22C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.174800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.096600E-03 |
| Normal-vs-Stage2 |
5.222000E-04 |
| Normal-vs-Stage3 |
1.940820E-03 |
| Normal-vs-Stage4 |
2.751200E-04 |
| Stage1-vs-Stage2 |
2.616000E-01 |
| Stage1-vs-Stage3 |
1.114830E-01 |
| Stage1-vs-Stage4 |
8.983800E-02 |
| Stage2-vs-Stage3 |
7.618800E-01 |
| Stage2-vs-Stage4 |
3.169800E-01 |
| Stage3-vs-Stage4 |
6.311600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.423700E-04 |
| Normal-vs-AfricanAmerican |
3.343000E-03 |
| Normal-vs-Asian |
2.330200E-01 |
| Caucasian-vs-AfricanAmerican |
9.756800E-01 |
| Caucasian-vs-Asian |
6.859000E-01 |
| AfricanAmerican-vs-Asian |
6.543400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.628700E-04 |
| Normal-vs-Female |
1.728560E-01 |
| Male-vs-Female |
1.025560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.839100E-04 |
| Normal-vs-Extreme_Weight |
3.769600E-04 |
| Normal-vs-Obese |
2.851900E-02 |
| Normal-vs-Extreme_Obese |
3.249800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.071400E-01 |
| Normal_Weight-vs-Obese |
1.772950E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.781000E-01 |
| Extreme_Weight-vs-Obese |
2.434200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.549200E-01 |
| Obese-vs-Extreme_Obese |
5.460800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.367900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.243200E-03 |
| Normal-vs-Age(61-80Yrs) |
8.046200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.124400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.432000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.874600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.704000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.331600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.434400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.679200E-03 |
| Normal-VS-Type2 PRCC |
1.65052999999693E-05 |
| Normal-VS-KIRP CIMP |
1.348230E-01 |
| Normal-VS-Unclassified PRCC |
2.168300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.757100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.461000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.470800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.008000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.777210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.095400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84718999999278E-05 |
| Normal-vs-N1 |
1.94662999999373E-05 |
| Normal-vs-N2 |
3.564200E-03 |
| N0-vs-N1 |
6.525800E-01 |
| N0-vs-N2 |
4.288400E-01 |
| N1-vs-N2 |
5.436800E-01 |
|
|
